First Turn Management’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,256,109
Closed -$17.3M 32
2026
Q1
$17.3M Buy
2,256,109
+363,426
+19% +$3.37M 1.93% 25
2025
Q4
$21.4M Buy
+1,892,683
New +$19.3M 2.45% 20

Other funds holding FULC

First Turn Management's FULC Position: Q2 2026 in Review

First Turn Management sold out of Fulcrum Therapeutics (FULC) in Q2 2026, closing a stake of 2,256,109 shares — an estimated $17.3M sold.

First Turn Management first reported a position in FULC in Q4 2025 and held it in 2 quarters. The position peaked at $21.4M in Q4 2025. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • First Turn Management reported no remaining Fulcrum Therapeutics position as of Q2 2026 after selling out during the quarter.
  • First Turn Management sold 2,256,109 Fulcrum Therapeutics shares in Q2 2026, an estimated $17.3M.
  • First Turn Management first reported a position in Fulcrum Therapeutics in Q4 2025 and held it in 2 quarters.
  • First Turn Management's Fulcrum Therapeutics position peaked at $21.4M in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on First Turn Management's 13F filing for Q2 2026, filed 14 Aug 2026.